{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreickju2mqbqdtcwheayeepeirifggq6apvlifg5mwqkuih4h4uufvm",
    "uri": "at://did:plc:eskrwciybv3pv2m4s34rimzk/app.bsky.feed.post/3mpecn5oyw2v2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreicw2kvmxwag4fyekuru3st3ltdmj4no4xxf7ls4xdwpfibgytwnni"
    },
    "mimeType": "image/jpeg",
    "size": 175255
  },
  "path": "/news/daewoong-luncurkan-envlo-di-indonesia-inovasi-baru-terapi-diabetes-di-asia",
  "publishedAt": "2026-06-28T13:45:00.000Z",
  "site": "https://www.jpnn.com",
  "tags": [
    "News",
    "Lifestyle",
    "obat antidiabetes"
  ],
  "textContent": "**JPNN.com** , JAKARTA - PT Daewoong Pharmaceutical Indonesia resmi meluncurkan ENVLO® atau Enavogliflozin 0,3 mg, obat antidiabetes generasi terbaru dari kelas SGLT2 inhibitor, dalam rangkaian FEN XIV & PIT PERKENI 2026.",
  "title": "Daewoong Luncurkan ENVLO® di Indonesia, Inovasi Baru Terapi Diabetes di Asia"
}